KRT18 and metabolic dysfunction-associated steatotic liver disease: Given that both hepatic and cardiac tissues express CK18, this study is aimed at investigating whether serum CK18 reflects concurrent cardiovascular alterations in NAFLD and at examining its mechanistic relevance through bioinformatics and single‐cell analyses.